In a new study, we found that one in ten US adults have overlapping risky alcohol use and obesity with implications for the use of GLP-1’s to mitigate these liver disease risk factors 👇

Check out our new editorial for the latest on evidence for GLP-1’s for the treatment on alcohol use disorder

In our national study of hospitalizations from 2016-2022, we describe overall stable rates of alcohol-related hospitalizations but increasing inpatient mortality, length of stay, patient complexity, and cost. Just published in @jamanetworkopen.com👇

🚨Our new paper in @jhospmedicine.bsky.social describes large hospital-level variation in initiation of medications for alcohol use disorder during alcohol withdrawal hospitalizations. Huge opportunity for increasing uptake of evidence based treatment! @cudivhospmed.bsky.social

Nearly one in 10 people with substance use disorders are hospitalized in a year, yet disorder treatment often isn’t available, says a new study by @cudeptofmedicine.bsky.social faculty @edenbernstein.bsky.social, Gina Kruse, MD, and Susan Calcaterra, MD, MPH. @cuanschutz.bsky.social #cucityofhealth

Excellent trial comparing oral vs injectable naltrexone at hospital discharge 👇

Hospitalizations present unmet opportunities for addiction treatment engagement. Our new paper in @annalsofim.bsky.social describes the prevalence of hospitalizations among adults with substance use disorders to inform the reach of hospital-based addiction treatment programs🧵

👋 #Medsky Check out our new paper on differences in post-hospitalization outcomes between Medicare Advantage and traditional Medicare beneficiaries with alcohol withdrawal and opioid overdose

1. Today the NIH director issued a new directive slashing overhead rates to 15%. I want to provide some context on what that means and why it matters. grants.nih.gov/grants/guide...

New @thelancet.bsky.social Editorial - American chaos: standing up for health and medicine www.thelancet.com/journals/lan... #MedSky #GastroSky

Excited to share our perspective in @nejm.org led by @trishasantos.bsky.social & @fabioethics.bsky.social Texas GA-46 threatens confidentiality and trust between clinicians and immigrants. We must advocate to protect privacy and ensure hospitals remain safe spaces.

Great to chat with @markharden.bsky.social about the link between alcohol and cancer in light of the recent surgeon general advisory!

Great summary of evidence for safety of naltrexone in liver disease 👇

We're making moves. Hello, Bluesky! 👋

🚨1 in 3 patients admitted to a VA with #AlcoholUseDisorder die in 5 yrs, with disproportionally high admissions in rural areas. Study by #Hospitalist Dr James Willey reinforces need for urgent action to address AUD in the veteran population. shmpublications.onlinelibrary.wiley.com/doi/full/10....